Dr Fiona McDonald
Clinical Consultant Oncologist, The Royal Marsden NHS Foundation Trust & Chair, UK SABR Consortium
Dr McDonald is a Consultant Thoracic Clinical Oncologist at The Royal Marsden NHS Foundation Trust and is on the faculty at the Institute of Cancer Research in London, UK. Her research aims to improve outcomes by developing individualised approaches to lung radiotherapy through integration of novel functional imaging, targeted biological agents and immunotherapy with advanced radiotherapy technologies, including stereotactic radiotherapy, intensity-modulated and image-guided adaptive radiotherapy. She is the deputy clinical lead in the International Research Consortium for novel developmental work on Magnetic Resonance (MR) guided radiotherapy for lung cancer and the chief investigator for the HALT trial investigating SBRT in oligo-progressive disease in patients with mutation positive NSCLC and the SARON trial investigating SBRT in synchronous oligo-metastatic NSCLC. Fiona additional roles include chair elect of the UK SABR consortium, steering committee member of the British Thoracic Oncology Group, member of the National Cancer Research Institute Lung Cancer Group and a member of the Advanced Radiotherapy Committee of the International Association for the Study of Lung Cancer.